Brief: Twist Bioscience Sees Q2 revenue $56.5 million

Twist Bioscience

03/02/2023 12:41

Feb 3 (Reuters) - Twist Bioscience:
* Outlook FY revenue USD 104-106 million.
* Outlook FY gross margin 39-40%
* Outlook Q2 revenue USD 56.5 million
* Outlook Q2 gross margin 30%
* Outlook FY capex USD 50 million